v3.26.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2025
Revenue Recognition [Abstract]  
Schedule of Disaggregated Revenue
Segment Net Sales
MedSurg and Neurotechnology:
2025
2024
2023
Instruments
$1,228
$1,069
$929
Endoscopy
3,807
3,389
3,068
Medical
4,204
3,852
3,459
Vascular
1,968
1,307
1,226
Neuro Cranial
2,485
2,136
1,876
$13,692
$11,753
$10,558
Orthopaedics:
Knees
$2,656
$2,447
$2,273
Hips
1,865
1,704
1,544
Trauma and Extremities
3,948
3,507
3,147
Ortho Tech
2,770
2,477
2,263
Spinal Implants
185
707
713
$11,424
$10,842
$9,940
Total
$25,116
$22,595
$20,498
United States Net Sales
MedSurg and Neurotechnology:
2025
2024
2023
Instruments
$1,072
$925
$800
Endoscopy
3,133
2,792
2,513
Medical
3,510
3,191
2,785
Vascular
1,048
506
483
Neuro Cranial
2,052
1,761
1,531
$10,815
$9,175
$8,112
Orthopaedics:
Knees
$1,924
$1,788
$1,676
Hips
1,137
1,059
988
Trauma and Extremities
2,926
2,586
2,297
Ortho Tech
2,086
1,846
1,684
Spinal Implants
118
489
500
$8,191
$7,768
$7,145
Total
$19,006
$16,943
$15,257
International Net Sales
MedSurg and Neurotechnology:
2025
2024
2023
Instruments
$156
$144
$129
Endoscopy
674
597
555
Medical
694
661
674
Vascular
920
801
743
Neuro Cranial
$433
375
345
$2,877
$2,578
$2,446
Orthopaedics:
Knees
$732
$659
$597
Hips
728
645
556
Trauma and Extremities
1,022
921
850
Ortho Tech
684
631
579
Spinal Implants
67
218
213
$3,233
$3,074
$2,795
Total
$6,110
$5,652
$5,241
Changes in Contract Liabilities Changes in
contract liabilities during the year were as follows:
2025
2024
Beginning contract liabilities
$978
$860
Revenue recognized from beginning of year contract
liabilities
(546)
(553)
Net advance consideration received during the period
592
671
Ending contract liabilities
$1,024
$978